Page 3 - Sun Pharma

Sun Pharma to launch Merck's Covid pill under brand name 'Molxvir' in India

Sun Pharmaceutical Industries said it is gearing up to introduce Merck Sharp Dohme and Ridgeback's molnupiravir under the brand name Molxvir in India

Leading drug makers Sun Pharma, Lupin recall products in US market

According to USFDA, the Mumbai-based drug maker is recalling the affected lot due to "failed moisture limits."

Stocks to Watch: SBI, Airtel, SpiceJet, Trent, Mtar, Pfizer, HPCL, Bata

SBI and other banking shares, along with stocks of companies to report earnings today will be in focus

Sun Pharma Q2 net up 13% at Rs 2,047 cr, firm launches 28 products in qtr

Taro-adjusted net profit down by 45% YoY

Sun Pharma second quarter net profit rises 13% to Rs 2,047 crore

The company had posted a net profit of Rs 1,812.79 crore for the corresponding period of the previous fiscal

Stocks to Watch: Airtel, Dabur, Sun Pharma, HDFC, IRCTC, Steel, Gold stocks

Gold and steel related stocks are likely to hog the limelight in trades on Tuesday. The former on the account of Dhanteras, while the latter owing to hike in steel prices

Q2 preview: Non-Covid revenues to hint at normalisation for healthcare cos

Companies may, however, report sequential drop in numbers as Q1FY22 coincided with outbreak of second Covid wave, say brokerages

Sun Pharma hits over 5-yr high on hopes of robust revenue growth in Q2

Motilal Oswal Securities remains positive on Sun Pharma due to investments in the global Specialty portfolio improving overall profitability

Sun Pharma gains 4% in 2 days after launching cough syrup Chericof 12

Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug

Aarti Inds, Bajaj Auto, Sun Pharma: Top stock picks by Ajit Mishra

While Aarti Industries and Sun Pharma have been consolidating in a range and awaiting a breakout, Bajaj Auto seems to have given a breakout, says the technical analyst from Religare Broking

Sun Pharma stock expected to keep market lead as firm recovers in US

Stock trading at the highest discount to ten-year valuation averages, as brokerages favour its US specialty portfolio.

Vivek Chaand Sehgal resigns as director from Sun Pharmaceutical board

Drug firm Sun Pharmaceutical Industries on Friday said Vivek Chaand Sehgal has resigned as an independent director of the company with effect from September 1.

Sun Pharma gets exclusive right to commercialise Winlevi acne cream in US

Sun Pharma and specialty pharma firm Cassiopea SpA announced consummation of their exclusive licence and supply agreements for Winlevi cream used for treatment of acne vulgaris

Top headlines: Sun Pharma's strong Q1 show, India-China military talks

Business Standard brings to you the top headlines on Saturday

Sun Pharma: Strong Q1 show, settlement of antitrust case pleases investors

Lack of pricing pressure, especially in the US, and debt reduction are other positives

Q1 results: Sun Pharma in the black, posts Rs 1,444-crore profit

Revenue from operations in the first quarter rose 29 per cent year-on-year and 14 per cent on a sequential basis to Rs 9,669 crore

Top headlines: Sun Pharma posts profit in Q1; Bandhan Bank Q1 net falls 32%

Business Standard brings you the top headlines on Friday

Sun Pharma posts consolidated net profit of Rs 1,444 crore in Q1

The company had posted a net loss of Rs 1,655.60 crore for the corresponding period of the previous fiscal

Sun Pharma rallies 9%, hits over 4-year high on strong June quarter results

The management said Sun Pharma witnessed a strong Q1, driven by a combination of robust core business growth, low base and some sale of Covid products

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced